Baytacare Pharmaceutical Co., Ltd. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2018. For the quarter, the company reported turnover was RMB 6,111,000 against RMB 1,993,000 a year ago. Operating loss was RMB 7,907,000 against RMB 5,469,000 a year ago. Loss before income tax expense was RMB 8,063,000 against RMB 5,648,000 a year ago. Loss attributable to owners of the company was RMB 7,997,000 against RMB 5,517,000 a year ago. Basic loss per share was 0.93 cents against 0.64 cents a year ago. For the nine months, the company reported turnover was RMB 13,208,000 against RMB 17,087,000 a year ago. Operating loss was RMB 15,416,000 against RMB 14,620,000 a year ago. Loss before income tax expense was RMB 15,885,000 against RMB 15,406,000 a year ago. Loss attributable to owners of the company was RMB 16,329,000 against RMB 15,110,000 a year ago. Basic loss per share was 1.90 cents against 1.76 cents a year ago.